Connect Sign InUpdate on the Laboratory Diagnosis of COVID-19
The current COVID-19 (SARS-CoV-2) pandemic is a rapidly evolving global situation and laboratories play an important part in its management. This presentation will review current information about the virology of SARS-CoV-2, highlight the current approaches used for diagnosis and surveillance of the virus, and discuss the benefits and limitations of current laboratory testing methodologies.
Dr. Kimberly E. Hanson is a medical director of mycology and section chief of clinical microbiology at ARUP Laboratories. She is also the head of immunocompromised host infectious diseases services at the University Hospital and Huntsman Cancer Center and a professor of medicine and pathology at the University of Utah School of Medicine. Dr. Hanson received her medical degree from Northwestern University. She served as the chief resident during her internal medicine residency at Dartmouth Hitchcock Medical Center. Following residency, she completed an infectious diseases fellowship, master’s degree in health sciences, and medical microbiology fellowship at Duke University Medical Center. Dr. Hanson is certified in medical microbiology by the American Board of Pathology and infectious disease by the American Board of Internal Medicine. She has received the Outstanding Fellow Research award at the 43rd Annual Meeting of the Infectious Diseases Society of America. Her research interests include the development and validation of novel cost-effective diagnostic tests for infectious diseases and transplant related infectious diseases and clinical diagnostics.
